Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

BodyLogicMD vs OlleveCare

BodyLogicMD
Graded #254

Higher grade

vs+17.199999999999996
OlleveCare
Graded #497

Lower grade

The verdict

BodyLogicMD takes it — 63.4/100 to 46.2/100.

BodyLogicMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. BodyLogicMD is a US telehealth and clinic network (operating since 2003) best known for bioidentical hormone replacement therapy, now offering medically supervised GLP-1 weight management alongside it.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBodyLogicMD +29
74
45
Dose & formulationEven
40
40
Clinical oversightBodyLogicMD +23
76
53
Labs & monitoringBodyLogicMD +15
64
49
FulfillmentBodyLogicMD +22
60
38
Contract termsBodyLogicMD +6
61
55
BodyLogicMD · left barOlleveCare · right bar

The numbers

MetricBodyLogicMDOlleveCare
WeighScore63.4/10046.2/100
GradeCC
Scorecard rank#254#497
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not published13 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
BodyLogicMD

Graded #254 · C

Strengths

  • Established since 2003 with board-certified specialists and a national network of local clinics plus telehealth
  • Integrates GLP-1 weight management with bioidentical hormone therapy and lab-based, whole-person protocols
  • Transparent $79/month membership, no insurance required, cancel anytime

Where it loses points

  • GLP-1 medication cost is not published — only the $79 membership fee is shown; drug type (compounded vs brand) not stated
  • Weight loss is secondary to the hormone-therapy core; not a GLP-1-first telehealth
  • State availability and dispensing pharmacy are not disclosed on the marketing site
OlleveCare

Graded #497 · C

Strengths

  • 13 states listed explicitly (VA, FL, AZ, MA, HI, IA, MD, NM, WA, KS, NY, DC, ID)
  • Both semaglutide and tirzepatide offered — switch molecules without switching platforms
  • Multi-service platform — GLP-1, virtual urgent care, and non-controlled refills with one provider
  • Cash-pay with a superbill option for out-of-network reimbursement
  • Founder Ahmed Emam is named in the footer

Where it loses points

  • Legal entity name not disclosed anywhere — can't be verified in a state registry
  • Pricing not shown before booking — you must enter the intake flow to see the fee
  • Pharmacy partner not named; model appears to fill at your preferred retail pharmacy
  • No medical director or prescribing clinician named — only 'board-certified providers'
  • No LegitScript badge, BBB profile, or HIPAA/SOC 2 seals displayed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard